Jump to content
  • Sign Up
  • Join Our Community!

    Get help in our celiac / gluten-free forum.

  • Jefferson Adams
    Jefferson Adams

    NLRP3 Inflammasome May Play Important Role in Celiac Development

    Reviewed and edited by a celiac disease expert.

      To learn more about the mechanisms driving inflammatory responses to certain antigens in foods, a team of researchers recently set out to see if p31-43 peptide (p31-43) from α-gliadin can trigger an innate immune response in the gut.


    Caption: The mice developed enteropathy in the proximal small intestine. Image: CC--Yu-Chan Chen

    Celiac.com 03/14/2019 - Researchers still don’t know much about the mechanisms driving inflammatory responses against certain antigens in food. To get more information, a team of researchers recently set out to see if p31-43 peptide (p31-43) from α-gliadin can trigger an innate immune response in the gut, and whether this might trigger pathological adaptive immunity. 

    The research team included María Florencia Gómez Castro, Emanuel Miculán, María Georgina Herrera, Carolina Ruera, Federico Perez, Eduardo Daniel Prieto, Exequiel Barrera, Sergio Pantano, Paula Carasi, and Fernando Gabriel Chirdo.

    They are variously affiliated with the Instituto de Estudios Inmunológicos y Fisiopatológicos (CONICET), Universidad Nacional de La Plata, La Plata, Argentina, the Instituto de Fisicoquímica y Químicas Biológicas, Dr. Alejandro Paladini (CONICET), Universidad de Buenos Aires, Buenos Aires, Argentina, the Laboratorio de Nanoscopía y Fisicoquímica de Superficies (CONICET), Universidad Nacional de La Plata, La Plata, Argentina, and the Biomolecular Simulations Group, Institut Pasteur de Montevideo, Montevideo, Uruguay.

    Researchers do not currently understand the receptors and mechanisms responsible for the induction of innate immunity by p31-43. In their recent paper on the subject, the research team offers evidence that conformational changes in the peptide may allow it to activate the NLRP3 inflammasome. 

    When researchers treated normal mice with p31-43, but not with scrambled or inverted peptides, the mice developed enteropathy in the proximal small intestine, which is associated with higher levels of type I interferon and mature IL-1β. 

    P31-43 demonstrated a sequence-specific spontaneous ability to form structured oligomers and aggregates in vitro and to activate the ASC speck complex. The enteropathy caused by p31-43 in live mice occurred only in the presence of NLRP3 or caspase 1, and was restricted by treatment with caspase 1 inhibitor Ac-YVAD-cmk. 

    Together, the data show that p31-43 gliadin naturally forms oligomers, which trigger the NLRP3 inflammasome. Moreover, this pathway is necessary for intestinal inflammation and pathology when p31-43 is given orally to mice. 

    This innate activation of the NLRP3 inflammasome could play a key role in the early stages of celiac disease development.

    Read more at Front Immunol. 2019
     


    User Feedback

    Recommended Comments

    I've had celiac disease for years and follow a strict gluten-free diet.  When I read the above article, all I could think about was the innocent little mice that are purposely made ill to advance science???  And we still do not have a cure for Celiac???  Why do scientists feel that they need to inflict God's little creatures with illnesses in the name of science?

     

    Share this comment


    Link to comment
    Share on other sites


    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • About Me

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University, and has authored more than 2,000 articles on celiac disease. His coursework includes studies in biology, anatomy, medicine, science, and advanced research, and scientific methods. He previously served as SF Health News Examiner for Examiner.com, and devised health and medical content for Sharecare.com. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of the book "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

×
×
  • Create New...